Abstract |
Treatment limitations exist for drug-resistant Acinetobacter baumannii central nervous system ( CNS) infection. We conducted a retrospective study and systematic literature review to identify patients with drug-resistant A. baumannii CNS infection who received primary or adjunct intrathecal or intraventricular (IT/IVT) colistin. In a case series of seven Thai patients and 17 patients identified in the literature, clinical and microbiological cure rates with IT/IVT colistin therapy were 83% and 92%, respectively. Three patients (13%) developed chemical ventriculitis and one (4%) experienced treatment-associated seizures. Death was associated with delayed IT/IVT colistin therapy compared to survival (mean time from diagnosis to IT/IVT colistin, 7 vs. 2 days; p 0.01). The only independent predictor of mortality was the severity of illness (APACHE II score > 19, adjusted odds ratio 49.5; 95% CI 1.7-1428.6; p 0.02). This case series suggests that administration of primary or adjunctive IT/IVT colistin therapy was effective for drug-resistant A. baumannii CNS infection.
|
Authors | T Khawcharoenporn, A Apisarnthanarak, L M Mundy |
Journal | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
(Clin Microbiol Infect)
Vol. 16
Issue 7
Pg. 888-94
(Jul 2010)
ISSN: 1469-0691 [Electronic] England |
PMID | 19686281
(Publication Type: Case Reports, Journal Article, Review, Systematic Review)
|
Chemical References |
- Anti-Bacterial Agents
- Colistin
|
Topics |
- APACHE
- Acinetobacter Infections
(drug therapy, microbiology)
- Acinetobacter baumannii
(drug effects)
- Adolescent
- Adult
- Aged
- Anti-Bacterial Agents
(administration & dosage, pharmacology, therapeutic use)
- Central Nervous System Bacterial Infections
(drug therapy, microbiology)
- Central Nervous System Infections
(drug therapy)
- Child
- Child, Preschool
- Colistin
(administration & dosage, adverse effects, pharmacology, therapeutic use)
- Cross Infection
(drug therapy, epidemiology, microbiology)
- Drug Resistance, Multiple, Bacterial
- Female
- Humans
- Injections, Intraventricular
- Injections, Spinal
- Male
- Middle Aged
- Risk Factors
- Thailand
- Treatment Outcome
|